Malin Wennström

Researcher, Associate professor, PhD, Master of science

Research areas and keywords

UKÄ subject classification

  • Medical and Health Sciences
  • Neurosciences


  • Alzheimers disease, pericytes, neuroinflammation, a stress, amyloid peptides, amyloid beta, amylin, glycogen, Amylase


Our goal is to identify new early mechanisms and biomarkers associated with Alzheimer’s disease (AD), and thereby improve development of new treatments and diagnostic tools. To do so we have over the years, together with national and international colleagues and collaborators, investigated the impact of AD risk factors (such as stress, inflammation, metabolic changes and amyloidogenesis) on different types of brain cells. Our scientific approach is to use translational studies primarily conducted on human samples (brain, retina, CSF and cells isolated from postmortem adult and fetal brain). By the use of such studies, we have revealed several new mechanisms and biomarkers associated with AD, including alteration of glycogen metabolism, toxicity/specificity of varios amyloid peptides and secretion of various pathology-specific molecules.  

Recent research outputs

Elin Byman, Isak Martinsson, Henriette Haukedal, Netherlands Brain Bank Netherlands Brain Bank, Gunnar Gouras, Kristine K Freude & Malin Wennström, 2021 Jul 14, In: Aging Cell. e13433.

Research output: Contribution to journalArticle

Giulia Treccani, Anna Lena Schlegelmilch, Nina Schultz, David P. Herzog, Joao M. Bessa, Ioannis Sotiropoulos, Marianne B. Müller & Malin Wennström, 2021, In: Stress. 24, 3, p. 353-358 6 p.

Research output: Contribution to journalArticle

View All (39)